胺碘酮诱导的甲状腺毒症中99m锝-甲氧基异丁基异腈甲状腺显像:功能成像与组织病理学的相关性
本文报告4例男性(年龄56-75岁)连续病例,均接受99m锝-甲氧基异丁基异腈甲状腺显像(99mTc-STS)及甲状腺组织学检查,结果均符合2型胺碘酮诱导的甲状腺毒症(AIT)诊断,为该诊断试验首次报道的组织病理学相关性。胺碘酮治疗中位时长26个月(范围10-39个月),4例均在术前中位3个月(范围2-4个月)停用胺碘酮。
要点
- 4例男性连续病例的99mTc-STS与甲状腺组织学均符合2型AIT诊断。
- 这是该诊断试验首次报道的组织病理学相关性。
- 胺碘酮治疗中位26个月,术前中位停药3个月。
核心结论
- 99mTc-STS是一种有前景的功能成像方法,可能有助于临床医生在AIT的诊断评估和治疗中提供帮助。
研究设计与样本
- 连续病例系列,共4例男性,年龄56-75岁,均接受99mTc-STS和甲状腺组织学检查。
主要发现
- 4例的99mTc-STS和甲状腺组织学均符合2型AIT诊断,为该诊断试验首次报道的组织病理学相关性。
- 胺碘酮治疗中位时长26个月(范围10-39个月)。
- 4例均在术前中位3个月(范围2-4个月)停用胺碘酮。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
99m Tc-sestamibi thyroid scintigraphy (STS) can aid in differentiating between types 1 and 2 amiodarone-induced thyrotoxicosis (AIT). We present a consecutive case series of 4 men (aged 56-75 years) in whom both 99m Tc-STS and thyroid histology were consistent with a diagnosis of type 2 AIT, representing the first reported histopathologic correlation for this diagnostic test. Median amiodarone treatment duration was 26 months (range, 10-39 months), and amiodarone was discontinued a median of 3 months preoperatively (range, 2-4 months) in all 4 cases. 99m Tc-STS is a promising functional imaging modality, which has the potential to aid clinicians in the diagnostic workup and treatment of AIT.
引用
- Wang R, Better N, Sivaratnam D, et al. 99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic Correlation. Clin Nucl Med. 2022. PMID: 35835112. doi:10.1097/RLU.0000000000004332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。